REGULATION OF CR2/CD21 EXPRESSION AND ACTIVATION
REGULATION OF CR2/CD21 EXPRESSION AND ACTIVATION
批准号:
6288216
负责人:
John Weis
金额:
$30.0万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1986
资助国家:
美国
项目状态:
已结题
起止时间:
1986-12-01 至 2006-01-31
关键词:
B cell receptor B lymphocyte antigen presentation biological signal transduction cell differentiation complement receptor dendritic cells genetic recombination genetic regulation genetic transcription introns laboratory mouse leukocyte activation /transformation receptor expression tissue /cell culture transfection
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (Applicant's Abstract): The murine CD21/Cr2 gene encodes two
proteins demonstrated to be critical in the acquisition of an optimal immune
response. Long considered as a phagocytic receptor for Complement-bearing
immune complexes, the CD21 pathway now includes signals for B-cell survival and
optimal activation, and presentation of native antigen by follicular dendritic
cells (FDC) in the germinal centers of the spleen. The expression of murine
CD21 is tightly controlled. The proteins are only found on B-cells during a
specific stage of differentiation, and are expressed by FDC once these cells
have taken up their position within the spleen.
This competing application proposes to continue the laboratories analysis of
the mechanism of CD21 gene control, and to initiate a new project to dissect
the transcriptional pathways that are activated (or inactivated) upon receptor
ligation. We propose that the transcription of the CD21 gene is regulated by a
set of transcription factors that are present in all lymphocytes and that the
lack of expression by T-cells is due to either (1) the presence of a site
specific, T-cell specific histone deacetylase, or (2) a site specific, B-cell
specific histone acetylase. Published and preliminary data supports DNA
accessibility as a primary determinant of CD21 expression in lymphocytes. In
vivohomologous recombination experiments are proposed to dissect the role of
key regulatory sites in the control of CD21 expression during B-cell
differentiation and by FDC.
The second major hypothesis to be tested is that B-cell activation via CD21
ligation, plus or minus surface Ig activation, leads to a pathway of
transcriptional control that directly influences the state of B-cell
differentiation and activation. Using novel gene analysis approaches, we
propose to fully characterize these transcriptional pathways for the expression
(depression) of known and novel genes. Elucidation of these pathways will lead
to means by such activation can be minimized when inappropriate, or accentuated
when required for the generation of an optimal B-cell response.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Role of Ifitm/Fragilis proteins as intracellular shuttles during cell activation
-
批准号:8043909
-
项目类别:
-
资助金额:$22.58万
-
财政年份:2010
-
负责人:John Weis
-
依托单位:
Role of Ifitm/Fragilis proteins as intracellular shuttles during cell activation
-
批准号:8197848
-
项目类别:
-
资助金额:$18.69万
-
财政年份:2010
-
负责人:John Weis
-
依托单位:
Regulation of CR2/CD21 Expression and Activation
-
批准号:7880369
-
项目类别:
-
资助金额:$1.3万
-
财政年份:2009
-
负责人:John Weis
-
依托单位:
Role of the Fragilis Proteins in the Immune Response
-
批准号:6894009
-
项目类别:
-
资助金额:$22.43万
-
财政年份:2004
-
负责人:John Weis
-
依托单位:
Role of the Fragilis Proteins in the Immune Response
-
批准号:6804271
-
项目类别:
-
资助金额:$18.69万
-
财政年份:2004
-
负责人:John Weis
-
依托单位:
Role of Pactolus in the innate immune response
-
批准号:6631980
-
项目类别:
-
资助金额:$33.75万
-
财政年份:1998
-
负责人:John Weis
-
依托单位:
PACTOLUS AND MAST CELL AND MORROW CELL FUNCTION
-
批准号:2705528
-
项目类别:
-
资助金额:$19.68万
-
财政年份:1998
-
负责人:John Weis
-
依托单位:
Role of Pactolus in the innate immune response
-
批准号:6886799
-
项目类别:
-
资助金额:$33.75万
-
财政年份:1998
-
负责人:John Weis
-
依托单位:
Role of Pactolus in the innate immune response
-
批准号:6721189
-
项目类别:
-
资助金额:$33.75万
-
财政年份:1998
-
负责人:John Weis
-
依托单位:
PACTOLUS AND MAST CELL AND MORROW CELL FUNCTION
-
批准号:2887616
-
项目类别:
-
资助金额:$20.27万
-
财政年份:1998
-
负责人:John Weis
-
依托单位:
PACTOLUS AND MAST CELL AND MORROW CELL FUNCTION
-
批准号:6170928
-
项目类别:
-
资助金额:$20.88万
-
财政年份:1998
-
负责人:John Weis
-
依托单位:
Role of Pactolus in the innate immune response
-
批准号:6400854
-
项目类别:
-
资助金额:$30.38万
-
财政年份:1998
-
负责人:John Weis
-
依托单位:
Role of Pactolus in the innate immune response
-
批准号:6510757
-
项目类别:
-
资助金额:$33.75万
-
财政年份:1998
-
负责人:John Weis
-
依托单位:
CHARACTERIZATION OF MAST CELL INTEGRINS
-
批准号:2067907
-
项目类别:
-
资助金额:$12.15万
-
财政年份:1993
-
负责人:John Weis
-
依托单位:
CHARACTERIZATION OF MAST CELL INTEGRINS
-
批准号:3148049
-
项目类别:
-
资助金额:$12.06万
-
财政年份:1993
-
负责人:John Weis
-
依托单位:
CHARACTERIZATION OF MAST CELL INTEGRINS
-
批准号:2067908
-
项目类别:
-
资助金额:$14.27万
-
财政年份:1993
-
负责人:John Weis
-
依托单位:
MOLECULAR CHARACTERIZATION OF CR1 AND RELATED PROTEINS
-
批准号:3136915
-
项目类别:
-
资助金额:$4.01万
-
财政年份:1986
-
负责人:John Weis
-
依托单位:
CHARACTERIZATION OF THE MURINE COMPLEMENT RECEPTORS
-
批准号:3136917
-
项目类别:
-
资助金额:$18.9万
-
财政年份:1986
-
负责人:John Weis
-
依托单位:
MURINE COMPLEMENT RECEPTOR CR2
-
批准号:6149754
-
项目类别:
-
资助金额:$23.92万
-
财政年份:1986
-
负责人:John Weis
-
依托单位:
MURINE COMPLEMENT RECEPTOR CR2
-
批准号:2871484
-
项目类别:
-
资助金额:$23.0万
-
财政年份:1986
-
负责人:John Weis
-
依托单位:
海外基金